Single Access for Transfemoral Transcatheter Aortic Valve Implantation With the Acurate neo/neo 2 Self-Expanding Valve

Transcatheter aortic valve implantation (TAVI) technologies have led to a reduction in delivery systems profiles and, along with expandable introducer sheaths, reducing the incidence of vascular complications. Nonetheless, a second arterial access is needed to landmark the aortic cusps and obtain a coplanar view for valve positioning and implantation.1,2 We aimed to report our single-centre experience of using a single-arterial access for TAVI with the Acurate neo/neo 2 (Boston Scientific, Marlborough, MA) self-expanding aortic bioprosthesis.